08:34 AM EST, 11/14/2025 (MT Newswires) -- CG Oncology ( CGON ) reported a Q3 net loss Friday of $0.57 per diluted share, widening from a loss of $0.30 a year earlier.

Analysts surveyed by FactSet expected a loss of $0.57 per share.

Revenue for the quarter ended Sept. 30 was $1.7 million, compared with $43,000 a year earlier.

Analysts polled by FactSet expected $0.1 million.